Search
Close this search box.

Guidance for Awake Prone Ventilation in the non-intubated Conscious Patient

Prone positioning in spontaneously breathing non-intubated COVID-19 patients This document provides guidance for African Union Member States on the use of awake prone positioning in non-intubated coronavirus disease (COVID-19) patients. It is intended for use among clinicians taking care of moderate to severe COVID-19 cases. The COVID-19 outbreak has brought with it the need for […]

Webinar Series on COVID-19 Genomic Surveillance in Africa

Topic: Main Routes of Entry and Genomic Diversity of SARS-CoV-2 in UgandaSpeaker: Prof. Matthew Cotten Professor of Pathogen Genomics and Bioinformatics MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda, and Professor in Viral Genomics MRC-University of Glasgow Centre for Virus Research, Glasgow, UKDate: Wednesday, 02 September 2020Time: 2:00PM – 3:00PM East Africa TimeLink: https://bit.ly/2Okfoqy

Guidance on Setting Up an Isolation Ward for COVID-19 Cases

Scope: The number of coronavirus disease 2019 (COVID-19) cases in Africa is increasing, and in many countries the number of cases has surpassed the number of available hospital beds. Because of the surge many countries are using tents or converting existing buildings into isolation wards. This document simplifies the WHO guidance on severe acute respiratory […]

Monitoring and Evaluation Framework for the Partnership to Accelerate COVID-19 Testing

Introduction: The Partnership to Accelerate COVID-19 Testing (PACT) initiative is a multi-pronged activity to increase the capacity of African Union Member States to Test, Trace, and Treat individuals with COVID-19. Implemented by the Africa Centres for Disease Control and Prevention (Africa CDC), it aims to support, in Africa, (a) conduct of 10 million COVID-19 tests; […]

Africa CDC Annual Progress Report 2019

CONTENTS THE YEAR IN BRIEF ……………………………………………………………………………………. 2 REGIONAL COLLABORATING CENTRES (RCCs) ……………………………………. 4 PUBLIC HEALTH INSTITUTES AND RESEARCH …………………………………….. 5 REGIONAL INTEGRATED SURVEILLANCE AND LABORATORY NETWORK (RISLNET) ………………………………………………………. 7 EMERGENCY PREPAREDNESS AND RESPONSE …………………………………… 8 DISEASE OUTBREAK RESPONSE SUPPORT  TO MEMBER STATES ……. 9 LABORATORY SYSTEMS AND NETWORKS ………………………………………….. 13 SURVEILLANCE AND DISEASE INTELLIGENCE …………………………………… […]

TRANSLATE THIS PAGE >